Treatment for Migraines 1 Week After D&C
For migraines occurring 1 week after a D&C procedure, the recommended first-line treatment is a combination of a triptan (such as sumatriptan) with an NSAID (such as ibuprofen, naproxen, or aspirin) or acetaminophen to maximize efficacy. 1, 2
First-Line Treatment Options
- For mild migraines, consider starting with an NSAID (aspirin, ibuprofen, naproxen, or diclofenac) or the combination of an NSAID with acetaminophen 1, 3
- For moderate to severe migraines, use a triptan (sumatriptan, rizatriptan, naratriptan, or zolmitriptan) combined with an NSAID or acetaminophen for improved efficacy 1, 2, 4
- Begin treatment as early as possible after migraine onset to maximize effectiveness 1, 3
- If using sumatriptan tablets, the recommended dose is 50 mg or 100 mg, with 50 mg often providing sufficient effect while minimizing side effects 5
Treatment Considerations After D&C
- Post-D&C migraines may be triggered by hormonal fluctuations, stress, or anesthesia effects, but the treatment approach remains the same as for typical migraines 2, 3
- For patients with significant nausea or vomiting (which may be more common after a procedure), consider:
Second-Line Options
- If first-line treatments are ineffective or not tolerated, consider:
Important Cautions
- Avoid opioids and butalbital-containing medications for migraine treatment, as they can lead to dependency and medication overuse headache 1, 3
- Limit acute treatments to no more than 2-3 days per week to prevent medication overuse headache 2, 3
- Triptans are contraindicated in patients with cardiovascular disease, uncontrolled hypertension, or history of stroke 2
- If a second dose of sumatriptan is needed, wait at least 2 hours after the first dose, and do not exceed 200 mg in a 24-hour period 5
Specific Treatment Algorithm
For mild migraine:
For moderate to severe migraine:
If significant nausea/vomiting is present:
If first treatment fails:
For frequent migraines (>4 per month):
Remember to monitor for medication overuse headache, which can develop if acute treatments are used ≥10 days/month for triptans or ≥15 days/month for NSAIDs 1, 2.